Partly as a result of this, a close relationship developed between the CTPA and FRAME, which has lasted for nearly 25 years and is based on a common commitment to making sufficient, and relevant and reliable, alternative methods available, so that cosmetic products can be as effective and safe as possible, without the need for animal testing.
There have been many notable achievements along the way, and FRAME's connections with the CTPA, as well as with the European Centre for the Validation of Alternative Methods (ECVAM) and the European Cosmetic, Toiletry and Perfumery Association (COLIPA), played a significant part in the evaluation and validation of non-animal methods for percutaneous absorption, phototoxicity and skin corrosivity, which are now accepted internationally by the industrial, regulatory and scientific communities.
However, despite much goodwill, good intentions and a huge amount of effort, many problems still remain, and the ethical, legal, political and scientific issues raised by the testing on animals of cosmetic products and ingredients, far from finding solutions, seem to become ever more and more complicated.
I will give some examples of my current concerns.
Growing Old Disgracefully
As Krys Bottrill 1 reveals in this issue of ATLA, despite the Government's claim that animal tests on cosmetic products and ingredients are no longer permitted, it is clear that a large and increasing number of mice are being used in the UK, to test batches of botulinum toxin to be used for cosmetic purposes, in an old-fashioned version of the LD50 test, which relies on paralysis and death, inevitably resulting in great suffering. The consequences for laboratory animal welfare of the increasingly avid use by fading celebrities and the general public of botulinum toxin as an antiwrinkle treatment have attracted very little attention, not only from the media (which does not surprise me), but also from organisations campaigning to stop animal testing for cosmetic purposes (which does).
The Government will no doubt claim that botulinum toxin preparations are tested because of their therapeutic uses, but the inescapable fact is that more and more of the toxin is being produced, and therefore has to be batch tested, directly as a result of its intended non-therapeutic use for cosmetic purposes.
Cosmetics versus Medicines
Botulinum toxin does not fall within the current definition of cosmetic product used in the European Union (EU), which refers to "any substance or preparation to be placed in contact with the various external parts of the human body . . . with a view to exclusively or mainly cleaning them, perfuming them, changing their appearance . . . and/or protecting them or keeping them in good condition". 2 The toxin is injected in the region where its paralytic effect on muscle contraction is desired.
In addition, cosmetic products are not intended to interact with and physiologically alter body tissues or their activities, as medicines are designed to do. Botulinum toxin clearly has an active physiological effect.
The current regulations in the EU recognise a product as either a cosmetic or a medicine, according to its properties and main purpose, whereas the USA recognises that there are products which cannot easily be assigned to one or the other of these two categories. This had led to the recognition of what are known as cosmeceuticals, which can serve either purpose, according to the specific circumstances. Partly for that reason, perhaps, the safety of cosmetics in the USA is handled by the Food and Drug Administration, rather than by another agency.
The use of botulinum toxin for cosmetic purposes represents a challenge to the EU regulatory system, which, in any case, will have to be reviewed in the near future, since the research activities of the cosmetic industry are increasingly focused on the development of products which will be biologically active, to the benefit of their users.
The Seventh Amendment to the EU Cosmetics Directive
In January this year, the European Parliament and the Council of the EU finally agreed on a text for a Seventh Amendment to Directive 76/768/EEC, 3 which requires that a ban on the animal testing of cosmetic products or products containing ingredients tested in animals, and on the marketing of such cosmetic products and ingredients, should come into effect six years after the entry into force of the Amendment. However, for three series of tests (repeated-dose toxicity [apparently including sensitisation testing], reproductive toxicity and toxicokinetics), the deadline for the prohibition of the marketing of cosmetic products for which those tests have been used will come into force only after ten years, with the possibility of further postponement in the event that no alternative methods are available.
Once again, as with the Sixth Amendment to the Directive, enacted in 1993, 2 the Seventh Amendment represents an uneasy compromise in an attempt to satisfy all the widely diverse positions held by the various stakeholders.
It was clear from the outset that the result of this compromise would be differing interpretations and legal arguments. Indeed, this has already begun, since the European Federation for Cosmetic Ingredients (EFfCI) 4 and the French Republic 5 have already taken action on legal and technical grounds against the European Parliament and the Council of the EU, in an attempt to block the enforcement of the Seventh Amendment.
I cannot understand why these actions have been initiated. However, they will inevitably cause embarrassment to COLIPA and its Steering Committee on Alternatives to Animal Testing (SCAAT), and to French companies, such as L'Oréal, which are committed to the replacement of animal testing as soon as possible, and which are intending to use the Seventh Amendment as a basis for significantly increasing cooperation between the industry, ECVAM, academia and animal welfare organisations, in order to speed up the development, validation and acceptance of alternative methods.
The Fundamental Problem
I have always believed that the fundamental problem in all of this lies with the desire of the animal rights movement to gain victories leading to the wearing of sackcloth and ashes, combined with the determination of some countries, regulators, companies and scientists to block all attempts to make them give up their beloved animal test procedures.
These irreconcilable stances are propped up by calls for bans and deadlines, and by the misguided legislation which seeks to introduce them. There is only one way forward -a combination of an all-out effort to develop and validate the necessary alternative test methods and testing strategies, together with an insistence that they be accepted and applied as soon as they become available, with the consequent ending of permission to conduct the equivalent animal tests. Only in this way will the need for animal tests be brought to an end, to the satisfaction and relief of the animal welfare movement, but without adverse effects on the legitimate commercial interests of industry or the well-being of the consumer.
Facing Up to the Future
As the botulinum toxin case illustrates, human vanity still exacts a high price in terms of animal suffering, and we are far from achieving beauty without cruelty. Even in this case, which involves the use of one of the most powerful poisons known, the Three Rs could be much more effectively applied. 1 It is particularly important to recognise that scientifically sound replacement alternative testing strategies are already known to be feasible, though urgently in need of further development and validation. I very much hope that Krys Bottrill's article will lead to the necessary action, with the full support of the Government.
I also hope that we can escape from the clamour for bans and from blocking legal actions, and instead use the Seventh Amendment to Directive 76/768/EEC to inspire and encourage greater collaborative effort to develop, validate and implement the scientifically advanced, replacement alternative test procedures which offer the only way of ensuring escape from the worthless wrangling which has already gone on for far too long. 
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